NHS patients to be prescribed Wegovy weight-loss jab for first time
The weight loss jab Wegovy is being made available in the UK as part of a controlled and limited launch.
The drug, also known as semaglutide, will be prescribed via specialist NHS weight management services alongside a reduced calorie diet and exercise from September 4.
Those eligible should have a body mass index (BMI) over 30 or a BMI of more than 27 and at least one weight-related co-morbidity.
The National Institute for Care and Excellence (Nice) gave Wegovy the green light for NHS use earlier this year.